Cited by 134SARS-CoV-2 and COVID-19 ResearchT-cell and B-cell ImmunologyImmune responses and vaccinations

Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets

Open access
Dugan, Haley L., Stamper, Christopher T., Li, Lei, Changrob, Siriruk, Asby, Nicholas W., Halfmann, Peter J., Zheng, Nai-Ying, Huang, Min +24 more·2021·Immunity

Abstract

Dissecting the evolution of memory B cells (MBCs) against SARS-CoV-2 is critical for understanding antibody recall upon secondary exposure. Here, we used single-cell sequencing to profile SARS-CoV-2-reactive B cells in 38 COVID-19 patients. Using oligo-tagged antigen baits, we isolated B cells specific to the SARS-CoV-2 spike, nucleoprotein (NP), open reading frame 8 (ORF8), and endemic human coronavirus (HCoV) spike proteins. SARS-CoV-2 spike-specific cells were enriched in the memory compartment of acutely infected and convalescent patients several months post symptom onset. With severe acute infection, substantial populations of endemic HCoV-reactive antibody-secreting cells were identified and possessed highly mutated variable genes, signifying preexisting immunity. Finally, MBCs exhibited pronounced maturation to NP and ORF8 over time, especially in older patients. Monoclonal antibodies against these targets were non-neutralizing and non-protective in vivo. These findings reveal antibody adaptation to non-neutralizing intracellular antigens during infection, emphasizing the importance of vaccination for inducing neutralizing spike-specific MBCs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2021.05.001

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dugan, H. L., Stamper, C. T., Li, L., Changrob, S., Asby, N. W., Halfmann, P. J., Zheng, N.-Y., Huang, M., Shaw, D. G., Cobb, M. S., Erickson, S. A., Guthmiller, J. J., Stovicek, O., Wang, J., Winkler, E. S., Madariaga, M. L., Shanmugarajah, K., Jansen, M. O., Amanat, F., Stewart, I., Utset, H. A., Huang, J., Nelson, C. A., Dai, Y.-N., Hall, P. D., Jedrzejczak, R. P., Joachimiak, A., Krammer, F., Diamond, M. S., Fremont, D. H., Kawaoka, Y., & Wilson, P. C.
Affiliations
  • University of Chicago (US)
  • University of Wisconsin–Madison (US)
  • Washington University in St. Louis (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • Argonne National Laboratory (US)
Corresponding author
Wilson, Patrick C.
Venue
Immunity
Publisher
Elsevier BV
Published
2021-06
Volume
54
Issue
6
Pages
1290-1303.e7
ISSN
1074-7613 (ISSN-L)
OpenAlex
W3157116442
Cited by
134
References
66
Citations by year
2026: 10 · 2025: 16 · 2024: 20 · 2023: 24 · 2022: 34 · 2021: 29 · 2013: 1
FWCI
8.46
Type
journal article
Language
en
Open access
Locations
  • Immunity (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (F30 AI152327, T32 CA009594, R01 AI157155, U19AI057266, U19AI082724, U19AI109946)
  • JPB Foundation
  • Icahn School of Medicine at Mount Sinai
  • Japan Agency for Medical Research and Development (R01 AI157155, F30 AI152327, JP19fk0108113, JP20fk0108272)
  • Open Philanthropy Project (2020-215611)
  • U.S. Department of Health and Human Services (HHSN272201700060C, HHSN272201400008C)
  • University of Chicago (SCR_019196, SCR_017760)
  • National Institute of Allergy and Infectious Diseases (75N93019C00062, 75N93019C00051, HHSN272201700060C)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords
SARS-CoV-2, memory B cells, immunodominance, non-neutralizing antibodies, nucleocapsid protein, ORF8, spike protein, antibody evolution, pre-existing immunity, B cell maturation, monoclonal antibodies, COVID-19 pandemic
MeSH terms
COVID-19, SARS-CoV-2, Antibodies, Viral, Antibody Formation, B-Lymphocytes, Cross Reactions, Female, Humans, Immunologic Memory, Male, Neutralization Tests, Immunodominant Epitopes, Epitope Mapping, Computational Biology, Gene Expression Profiling, Host-Pathogen Interactions, Antibodies, Neutralizing, Single-Cell Analysis, High-Throughput Nucleotide Sequencing, Transcriptome, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review